Literature DB >> 19807739

Two novel AIRE mutations in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) among Indians.

G Zaidi1, R P Sahu, L Zhang, G George, N Bhavani, N Shah, V Bhatia, A Bhansali, G Jevalikar, R V Jayakumar, G S Eisenbarth, E Bhatia.   

Abstract

Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) is a rare recessive disorder resulting from mutations in the autoimmune regulator (AIRE) gene. There is no information on AIRE mutations in Indians. In a cross-sectional study, nine patients (eight families), from four referral hospitals in India, were studied for AIRE mutations by direct sequencing. We screened for new mutations in 150 controls by allele-specific PCR. The patients had 1-7 known components of APECED. Three patients had unusual manifestations: presentation with type 1 diabetes; chronic sinusitis and otitis media; and facial dysmorphism. All patients carried homozygous, probably recessive, AIRE mutations. Two unrelated patients from a small in-bred community (Vanika Vaisya) in south India carried an unreported missense mutation, p.V80G, in the N-terminal caspase recruitment domain. Another unique mutation, p.C302X, resulting in a truncated protein with deletion of both zinc-finger domains, was detected in a patient from Gujarat. Neither mutation was detected in controls. Other mutations, previously described in Caucasians, were: 13 base pair deletion (p.C322fsX372) in 4 (38%), and Finn-major (p.R257X) and p.R139X (Sardinian) mutation in one subject each. In conclusion, in this first series of APECED in Indians, we detected AIRE mutations previously reported in Caucasians, as well as unique mutations. Of these, p.V80G is possibly an ancestral mutation in an in-bred community.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19807739     DOI: 10.1111/j.1399-0004.2009.01280.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  6 in total

Review 1.  Autoimmune polyendocrine syndrome type 1 (APECED) in the Indian population: case report and review of a series of 45 patients.

Authors:  A Fierabracci; A Arena; F Toto; N Gallo; A Puel; M Migaud; M Kumar; K G Chengappa; R Gulati; V S Negi; C Betterle
Journal:  J Endocrinol Invest       Date:  2020-08-07       Impact factor: 4.256

2.  Deletion of GPIHBP1 causing severe chylomicronemia.

Authors:  Jonathan J Rios; Savitha Shastry; Juan Jasso; Natalie Hauser; Abhimanyu Garg; André Bensadoun; Jonathan C Cohen; Helen H Hobbs
Journal:  J Inherit Metab Dis       Date:  2011-10-19       Impact factor: 4.982

3.  Autoimmune polyendocrine syndrome type 1 in an Indian cohort: a longitudinal study.

Authors:  Ghazala Zaidi; Vijayalakshmi Bhatia; Saroj K Sahoo; Aditya Narayan Sarangi; Niharika Bharti; Li Zhang; Liping Yu; Daniel Eriksson; Sophie Bensing; Olle Kämpe; Nisha Bharani; Surendra Kumar Yachha; Anil Bhansali; Alok Sachan; Vandana Jain; Nalini Shah; Rakesh Aggarwal; Amita Aggarwal; Muthuswamy Srinivasan; Sarita Agarwal; Eesh Bhatia
Journal:  Endocr Connect       Date:  2017-04-26       Impact factor: 3.335

Review 4.  Autoimmune Addison's Disease as Part of the Autoimmune Polyglandular Syndrome Type 1: Historical Overview and Current Evidence.

Authors:  Roberto Perniola; Alessandra Fierabracci; Alberto Falorni
Journal:  Front Immunol       Date:  2021-02-26       Impact factor: 7.561

5.  Molecular and clinical characterization of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome (APECED) in Iranian non-Jewish patients: report of two novel AIRE gene pathogenic variants.

Authors:  Aria Setoodeh; Samareh Panjeh-Shahi; Fariba Bahmani; Fatemeh Vand-Rajabpour; Nazanin Jalilian; Fatemeh Sayarifard; Farzaneh Abbasi; Azadeh Sayarifard; Parastoo Rostami; Nima Parvaneh; Haleh Akhavan-Niaki; Mohamadreza Ahmadifard; Mina Tabrizi
Journal:  Orphanet J Rare Dis       Date:  2022-01-06       Impact factor: 4.123

6.  Autoimmune polyglandular syndrome type 1 with diabetes insipidus: a case report.

Authors:  JiaQi Chen; Ting Lu; ChenXiao Liu; Yun Zhao; AiJie Huang; XingNa Hu; Min Li; Rong Xiang; Min Feng; HongHong Lu
Journal:  BMC Endocr Disord       Date:  2021-08-03       Impact factor: 2.763

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.